Bioprocessing & Manufacturing

 

 

With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing.

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Academics And Research Institutions

 

Job Titles

 

• Head of Bioprocessing
• Head of Manufacturing
• Head of Formulation
• Head of Biopharmaceutical
Development
• Head of Upstream / Downstream Process
• Head of R&D
• Head of Procurement
• Head of CMC

Who Should Sponsor?

 

• Big Pharma
• Biotechs
• Contract Research Organizations
• Contract Manufacturing Organizations
• OEMs / Equipment Manufacturers
• Platform Technology Providers
• Logistics / Cold Chain

 

Bioprocessing & Manufacturing Conference, Tuesday 16 April 2019

Bioprocessing & Manufacturing Conference
09:00

Chair's opening remarks

Vaccine Bioprocessing Trends and Challenges

Antu Dey
Bioprocessing & Manufacturing Conference
09:10

New Models: How are smaller product development organizations (biotechs/non-profit/academics) manufacturing vaccine products for early and exploratory PoC clinical trials? Are larger Biopharma adaptin

  • How are non-profits and academics de-risking earlier staged vaccine research before further development?
  • Strategy in collaborative models
  • A new shift in how vaccines are developed, how does this compare to 10 years ago? Is there a new emphasis on testing in humans earlier?
  • Pharma vision – is there a growing gap in end to end processing expertise?
Bioprocessing & Manufacturing Conference
10:10

Process & Product Development using new technologies & Regulatory challenges in entering clinic

10:40

Networking Coffee Break

Designing Vaccines for Global Health

Dr Christopher Yallop
Bioprocessing & Manufacturing Conference
11:40

Latest advancements in production process intensification to support demand for affordable vaccines

Bioprocessing & Manufacturing Conference
11:55

Bridging the global health gap – Viral and bacterial vaccine development

Senior representative, Intravacc
Bioprocessing & Manufacturing Conference
12:10

Outsource manufacturing of your vaccine candidate: The do’s and don’ts

Senior representative, Wacker Biotech
Bioprocessing & Manufacturing Conference
12:40

Establishing manufacturing capabilities in developing markets

13:10

Networking Lunch & Poster Session

Vaccine Production for Outbreaks

Peter Khoury
Bioprocessing & Manufacturing Conference
14:40

Vaccine self-sufficiency and responding to pandemic outbreaks from small to large scale

Bioprocessing & Manufacturing Conference
15:10

Accelerating vaccine production as part of a rapid response system

Reserved for GE Healthcare
Bioprocessing & Manufacturing Conference
15:40

Initiating international multi-stakeholder collaborations from public heath, government and manufacturers

Reserved for Millipore Sigma
16:09

Networking Coffee Break

Alternative Delivery Platforms

Erin Spiegel
Bioprocessing & Manufacturing Conference
16:40

Alternative delivery system technology showcase

  • Expanding vaccine effectiveness with needle-free delivery
Reinhard Braun
Bioprocessing & Manufacturing Conference
16:55

Alternative delivery system technology showcase

  • Clinical milestone in skin vaccination: Combining the P.L.E.A.S.E.® epidermal system with the dry-patch technology boosts immunogenicity in an adjuvant-free setting
Tom Lake
Bioprocessing & Manufacturing Conference
17:10

Alternative delivery system technology showcase

  • Microprojection array patch clinical study with influenza vaccine: Demonstration of efficacy, dose reduction, and high temperature stability
Bioprocessing & Manufacturing Conference
17:25

Alternative delivery system technology showcase

Mucosal delivery routes
Darin Zehrung
Bioprocessing & Manufacturing Conference
17:40

The Delivery Board: Reviewing presentations and their effectiveness

  • How does different routes of delivery influence the immunological outcome?
  • Effectiveness and usability
18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, follow the congress team

last published: 14/Dec/18 13:15

Bioprocessing & Manufacturing Conference, Wednesday 17 April 2019

Bioprocessing & Manufacturing Conference
09:00

Chair's opening remarks

Manufacturing Platforms

Bioprocessing & Manufacturing Conference
09:10

Manufacturing technology showcase: Stockpiling heat stable oral vaccines to combat emerging disease

Andrew Lees
Bioprocessing & Manufacturing Conference
09:25

Manufacturing technology showcase: Development of EcoCRM®, a new GMP CRM197 carrier protein

Bioprocessing & Manufacturing Conference
09:40

Manufacturing technology showcase

Practical solutions enabling rapid and sustainable productionSenior representation, Paragon
Dr Alexander Koglin
Bioprocessing & Manufacturing Conference
10:10

Manufacturing technology showcase: Scalable in vitro manufacturing of tailored vaccines

Bioprocessing & Manufacturing Conference
10:25

Manufacturing technology showcase

Affinity chromatography for vaccines purification
10:40

Networking Coffee Break

Bioprocessing & Manufacturing Conference
11:30

Incorporating AI and big data into more effective vaccine manufacturing

Dr Kc Cheng
Bioprocessing & Manufacturing Conference
12:00

Expectations and CMC strategies for infectious disease monoclonal antibodies

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 14/Dec/18 13:15

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071